$1.52
-0.06 (-3.80%)
Open$1.58
Previous Close$1.58
Day High$1.58
Day Low$1.50
52W High$270.25
52W Low—
Volume—
Avg Volume17.90M
Market Cap3.35M
P/E Ratio—
EPS$-25.66
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 398.2K | 400.3K | 406.3K |
| Net Income | -29,112 | -35,289 | -31,464 |
| Profit Margin | -7.3% | -8.8% | -7.7% |
| EBITDA | -48,158 | -49,842 | -45,919 |
| Free Cash Flow | -34,661 | -49,903 | -42,011 |
| Rev Growth | +16.9% | +4.6% | -8.7% |
| Debt/Equity | 0.13 | 0.15 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $254.31 | +0.38% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $360.55 | +0.62% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.33 | -1.21% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $499.65 | +1.69% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $631.81 | -0.17% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.52 | +0.74% | 69.3 | 39.97B |